In September 2026 a company backed by the Gates Foundation launched a new vitamin A product meant for everyday foods across large parts of Africa. The product wraps the vitamin in tiny polymer particles so more of it survives heat and humidity. Supporters say this can help millions of children avoid blindness and early death. Critics ask whether the long-term effects of the particles themselves have been studied enough before they reach hundreds of millions of people. Both sides rest on public documents, company statements, and published research. The gap between those two views is where the real questions sit.
The Problem the Particles Aim to Solve
Vitamin A deficiency remains common in parts of sub-Saharan Africa and South Asia. Health agencies estimate that roughly 190 million preschool children and 19 million pregnant women lack enough of the vitamin. Severe shortages can cause night blindness, full blindness, and higher death rates from common infections. Adding the vitamin to staple foods such as flour, sugar, or bouillon cubes has been tried for years. The catch is that vitamin A breaks down quickly in hot, humid storage and during cooking. Studies have shown losses as high as 85 percent before the food reaches the plate. That is the practical problem Particles for Humanity set out to fix with its PFH-VAP technology, now sold as VIT A+.
The idea is simple on paper. Coat the vitamin in a protective shell so it stays intact longer, then release it once it reaches the acid in the stomach. The shell is made from a material called basic methacrylate copolymer, or BMC. MIT researchers first showed the approach could work for several nutrients, including iron and vitamin A, in papers published around 2019 and later. Small human tests found that people absorbed the protected vitamin at levels close to unprotected vitamin A. Gates Foundation grants supported the work and later the company that commercialized it.
How the Technology Moved from Lab to Market
Particles for Humanity, a benefit corporation based in Cambridge, Massachusetts, received multiple grants from the Gates Foundation. Public foundation records and company announcements put the total well above 30 million dollars across several awards between 2019 and 2024. The money paid for formulation work, manufacturing scale-up, and efforts to place the product into existing African fortification programs. In late September 2026 Hexagon Nutrition launched VIT A+ at a micronutrient conference in Accra, Ghana. The company said each production batch can fortify about 600 million servings of food. Target foods include bouillon, which is used in most West African households, as well as wheat flour and sugar.
Company materials claim the coated version keeps more than three to four times as much vitamin A as a standard commercial product after a year of harsh storage. A human absorption study that began enrolling in Zambia in 2025 is meant to check whether that extra stability actually delivers more vitamin into the body. Codex, the international food standards body, has expanded the list of foods in which BMC can be used. European authorities have allowed the same copolymer in food supplements for years. MIT researchers themselves later noted that the original BMC does not break down easily in the environment and have worked on biodegradable alternatives that dissolve into simpler components during cooking.
Supporters point to these regulatory steps and the stability data as reasons to move forward. They argue that conventional fortification already loses most of its vitamin A in real African conditions, so a more stable form is worth trying. They also note that BMC has a long history of use as a coating on pills and that high-molecular-weight polymers of this type are poorly absorbed by the gut.
🚨GATES-FUNDED SYNTHETIC POLYMER MICROPARTICLES TO TARGET HUNDREDS OF MILLIONS OF AFRICANS THROUGH THE FOOD SUPPLY The Gates Foundation poured over $30 MILLION into a company called “PARTICLES FOR HUMANITY,” which aims to expose HUNDREDS OF MILLIONS of Africans to these largely untested microparticles. In September 2026, the company launched VIT A+, designed to introduce synthetic polymer-encapsulated vitamin A into everyday foods. They claim the synthetic polymer is designed to protect vitamin A from degrading during cooking and storage. But conventional vitamin A fortification already exists, and this new formulation has NOT demonstrated reductions in blindness or mortality. Even more concerning, one formulation contains BHA and BHT, two synthetic preservatives. BHA is classified as reasonably anticipated to be a human CARCINOGEN based on animal studies. It remains unclear whether these hazardous preservatives are included in the final commercial product. The long-term effects of repeated consumption of this synthetic polymer microparticle formulation, particularly among children and pregnant women, have NOT been adequately studied.
— Nicolas Hulscher, MPH (@NicHulscher) November 9, 2026
What Critics Are Pointing To
Alternative outlets and researchers such as Nicolas Hulscher have focused on three points. First, the scale: the stated goal is to reach hundreds of millions of people through everyday foods rather than through optional supplements. Second, the limited long-term data on repeated consumption of the polymer particles by children and pregnant women. Third, reports that at least one development formulation contained the preservatives BHA and BHT. BHA has been listed by the U.S. National Toxicology Program as “reasonably anticipated to be a human carcinogen” on the basis of animal studies since 1991. The FDA opened a formal reassessment of BHA’s safety in food in early 2026. It is not clear from public company documents whether BHA or BHT remain in the final commercial VIT A+ product. Company statements emphasize the BMC coating and do not list those preservatives as ingredients in the marketed version.
Critics also note that the product has not yet shown, in large outcome trials, that it actually reduces blindness or child deaths compared with existing fortification methods. Absorption studies are still underway. They place the project in a wider pattern of Gates-supported technologies tested or rolled out in Africa, from certain vaccines to genetically modified crops and digital identification systems. Some of those earlier efforts have drawn mixed results or strong local opposition, as documented in reports on the Alliance for a Green Revolution in Africa (AGRA). Recent analyses have found that hunger rose rather than fell in several AGRA focus countries over nearly two decades. Readers who want more context on other Gates-linked technologies can look at reporting on quantum-dot skin marks for vaccine records and on carbon nanodots found in certain soft drinks.
The polymer protects the vitamin. Whether the polymer itself needs more protection for the people who will eat it every day is the open question.
What the Safety Data Actually Show So Far
EFSA, the European food safety agency, reviewed BMC years ago for use as a coating on supplements. It found no genotoxicity concern and high margins of safety at expected exposure levels because the polymer is large and poorly absorbed. MIT work showed that the particles release their nutrient load in gastric acid and that short-term human absorption of the nutrient was acceptable. Those findings support the claim that the coating does its job of delivering the vitamin. They do not, by themselves, answer questions about decades of daily intake of the polymer by growing children or about environmental accumulation if the particles are not fully degraded.
On the preservative issue, the FDA’s 2026 review of BHA is independent of this product. The agency is looking at BHA because it is still used in many ordinary foods and because animal data have long raised flags. Whether any amount of BHA was present in early Particles for Humanity batches, and whether it is present now, is not settled in the public record that was available as of November 2026. That uncertainty is itself part of the debate: full ingredient transparency for a product intended for mass fortification would allow outside scientists to check residual levels.
The Practical Trade-Offs
Food fortification has a proven track record when the nutrient actually reaches people. Iodized salt is the classic example. Vitamin A fortification has been less reliable in tropical climates precisely because of the stability problem the new particles address. If the stability gains hold up in real supply chains and if absorption studies confirm higher body levels, the product could deliver more usable vitamin at roughly the same cost. That is the upside the developers and funders emphasize.
The downside is the speed and scale of introduction relative to the depth of long-term human data. Most of the published safety work on BMC concerns coating on occasional pills, not continuous presence in staple foods eaten by young children. Environmental persistence of the original polymer has already been flagged by the MIT team that invented it. Informed consent at the level of national fortification programs is different from consent in a clinical trial. These are ordinary governance questions that arise whenever a new material moves from the laboratory into the daily diet of large populations.
Where Things Stand
VIT A+ is now commercially available for fortification programs in Africa. Manufacturing has been validated at commercial scale. Absorption studies continue. Regulatory bodies have cleared the polymer for certain uses. Independent long-term outcome data on blindness or mortality are not yet public. Full disclosure of every excipient in every batch is not uniformly available in open sources. Readers who want the primary documents can start with the Gates Foundation grant pages, the Particles for Humanity technical summaries, the MIT Science Translational Medicine paper on the microparticle platform, the EFSA opinion on BMC, and the FDA’s 2026 request for information on BHA.
The technology is neither a secret plot nor a finished success. It is a concrete attempt to solve a real nutrient-loss problem with a synthetic coating, backed by substantial philanthropic money and now entering African food systems. The strength of the stability data is clear. The completeness of the long-term safety picture for mass daily use is still being filled in. Both of those facts can be true at the same time.
Original source and date: The People’s Voice, 10 November 2026. Related primary reporting includes the September 2026 Hexagon Nutrition / Particles for Humanity launch announcement and the Nicolas Hulscher post of 9 November 2026. See also Gates-linked quantum-dot work and carbon nanodot findings for wider context on related technologies.
Disclaimer for readers and fact-checkers: This piece draws on company statements, foundation grant records, peer-reviewed papers, regulatory opinions, and alternative-media coverage. Claims that the marketed product contains BHA rest on reports about development formulations; public commercial materials do not list it. The main encapsulation polymer has received regulatory clearances for certain uses. Large-scale health-outcome results are not yet available. Readers should consult the primary sources linked above before drawing final conclusions.
Original article: Bill Gates-Funded Vitamin A Particles Enter African Food: What We Know on Planet Today 🚀
Automatically republished from the main blog.